Dr. Patrick Lee, PhD Professor Department of Microbiology & Immunology Faculty of Medicine Dalhousie University, Halifax, NS, Canada Dr. Lee’s approach to the treatment of prostate cancer is evolutionary, forward-looking, and revolutionary: a focus on the reovirus, a naturally-occuring benign human virus. The reovirus is used directly to infect cancer cells and indirectly to activate the body’s immune system against cancer cells. Dr. Lee’s presentation at the October 2011 PCC Conference in Halifax was a definite highlight and we are thrilled that he was our special Prostate Cancer Week Awareness Night speaker. CLICK ON THE ARROW TO START …
Long-term quality of life for men who have undergone radical prostatectomy (RP) is inextricably tied to urinary incontinence (UI) issues. Robert K. Nam, MD, MSc, and colleagues helped to shed light on the impact of this side effect by studying rates of UI-corrective surgery occurring up to 15 years following radical prostatectomy. Read More.
In this Issue We welcome Dr. Patrick Lee Clinic celebrates 5 years Two new clinics opening Dr. Patrick Lee North York Harvest Food Bank Thank you to Scotiabank Pictures of our Walk/Run Meet Denis Farbstein PCCN Regina conference Dr. Uri Lindner 2nd annual AIM meeting Pictures from volunteers dinner On-going Projects for 2012 PCCN-Toronto Board of Directors Read it by clicking the link below to open the pdf file: Awareness: The PCCN-Toronto and Side by Side Prostate Cancer Support Groups Newsletter September 2012 (pdf)
A widely used breast cancer drug may ease the side effects of prostate cancer treatment, according to a new German study. Scientists examined four studies involving men in Europe and North America undergoing therapy for prostate cancer, the common side effects of which are gynecomastia (breast enlargement) or breast pain. Read More.